Performance of TechLab C. DIFF QUIK CHEK™ and TechLab C. DIFFICILE TOX A/B II™ for the detection of Clostridium difficile in stool samples

Diagnostic Microbiology and Infectious Disease

Volumn 59, Issue 1, 2007, Pages 33-37

  Reyes, Romina C ^a   John, Michael A ^a   Ayotte, Diane L ^a   Covacich, Alexia ^a   Milburn, Susan ^a   Hussain, Zafar ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Clostridium difficile; Diarrhea; Membrane immunoassay

Indexed keywords

GLUTAMATE DEHYDROGENASE;

ANIMAL CELL; ARTICLE; BACTERIUM CULTURE; CLOSTRIDIUM DIFFICILE; CYTOTOXICITY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; EVALUATION; FECES ANALYSIS; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; FECES; HUMANS; IMMUNOENZYME TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 34548593193     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.04.018     Document Type: Article

References (19)

1. Barbut F., Daprey G., Cohen P., Marle N., Burghoffer B., and Petit J.C. Usefulness of simultaneous detection of toxin A and glutamate dehydrogenase for the diagnosis of Clostridium difficile-associated disease. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 481-484
2. Barbut F., Delemée M., Brazier J.S., Petit J.C., Poxton I.R., Rupnil M., Lalande V., Schneider C., Mastrantonio P., Alonso R., Kuipjer E., Tevede M., and ESCMID group on Clostridium difficile. European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin. Microbiol. Infect. 9 (2003) 989-996
3. Borek A.P., Aird D.Z., and Carroll K.C. Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile. J. Clin. Microbiol. 43 (2005) 2994-2995
4. Brazier J.S. The diagnosis of Clostridium difficile-associated disease. J. Antimicrob. Chemother. 41 Suppl. C (1998) 29-40
5. Doern G.V., Coughlin T., and Wu L. Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A and two cytotoxicity assays. J. Clin. Microbiol. 30 (1991) 2041-2046
6. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. J. Clin. Microbiol. 92 (1997) 730-750
7. George W.L., Sutter V.L., Ciron D., and Feingold S.M. Selective differential medium for isolation of Clostridium difficile. J. Clin. Microbiol. 9 (1979) 214-219
8. Gerding D.N., Johnson S., Peterson L.R., Mulligan M.E., and Silva Jr. J. Clostridium difficile-associated diarrhea and colitis. Infect. Control Hosp. Epidemiol. 16 (1995) 459-477
9. Johnson S., Sambol S.P., Brazier J.S., Delmëe M., Avesani V., Merrigan M.M., and Gerding D.N. International typing study of toxin A-Negative, toxin B-positive Clostridium difficile variants. J. Clin. Microbiol. 41 (2003) 1543-1547
10. Kyne L., Hamel B., Polavaram R., and Kelly C.P. Health care costs and mortality associated with diarrhea due to Clostridium difficile. Clin. Infect. Dis. 34 (2002) 346-353
11. Landry M.L., Topal J., Ferguson D., Giudetti D., and Tang Y. Evaluation of Triage Clostridium difficile panels for rapid detection of Clostridium difficile in stool samples. J. Clin. Microbiol. 39 (2001) 1855-1858
12. Laughon B.E., Viscidi R.P., Godovin S.L., Yolken R.H., and Bartlett J.G. Enzyme immunoassay for the detection of Clostridium difficile toxin A and B in fecal specimens. J. Infect. Dis. 149 (1984) 781-788
13. McFarland L.V., Mulligan M.E., Kwok R.Y., and Stamm W.E. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 320 (1989) 204-210
14. Pėpin J., Valiquette L., Alary M.E., Villemure P., Pelletier A., Forget K., Pëpin K., and Chouinard D. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171 (2004) 466-472
15. Snell H., Ramos M., Longo S., John M., and Hussain Z. Performance of the TechLab C. DIFF CHECK-60 enzyme immunoassay (EIA) in combination with the C. difficile TOX A/B II EIA kit, the triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 42 (2004) 4863-4865
16. Ticehurst J.R., Aird D.Z., Dam L., Borek A.P., Hargrove J.T., and Carrill K.C. Effective detection of toxogenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J. Clin. Microbiol. 44 (2006) 1145-1149
17. Wilkins T.D., and Lyerle D.M. Clostridium difficile testing after 20 years, still challenging. J. Clin. Microbiol. 41 (2003) 531-534
18. Wolcox M.H. Clostridium difficile infection: appendix. J. Antimicrob. Chemother. 41 Suppl. C (1998) 71-72
19. Zheng L., Keller S.F., Lyerle D.M., Carmen R.J., Genheimer C.W., Gleaves C.A., Kohlhepp S.J., Young R.J., Perez S., and Ye K. Multicentre evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J. Clin. Microbiol. 42 (2004) 3837-3840